Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Comvita ( (NZ:CVT) ) has provided an update.
Comvita has completed a major capital raising, issuing 59,277,289 new ordinary shares through a pro-rata rights offer and a strategic placement, expanding its total shares on issue to 129,839,035. The new shares, priced at NZ$0.65 under the rights offer and NZ$0.80 under the placement, rank equally with existing fully paid ordinary shares, significantly enlarging the company’s equity base.
The capital raising structure brought in F&N Ventures Pte. Ltd. as a strategic shareholder via the placement, which also underwrote a substantial portion of the rights offer to provide funding certainty. Comvita emphasised objectives of certainty, fairness and minimising dilution, including an oversubscription facility that allowed existing shareholders to maintain their pro-rata holdings post-placement, signalling a balancing of strategic capital needs with shareholder interests.
More about Comvita
Comvita Limited is a New Zealand-listed company focused on producing and marketing natural health products, with a particular emphasis on honey-based offerings. The company’s ordinary shares trade on the NZX under the ticker CVT, and its capital structure adjustments reflect ongoing efforts to support strategic growth initiatives in its core markets.
YTD Price Performance: 41.15%
Average Trading Volume: 265,906
Technical Sentiment Signal: Sell
Current Market Cap: N$82.84M
Learn more about CVT stock on TipRanks’ Stock Analysis page.